Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0179
+0.0019 (11.72%)
Oct 15, 2025, 3:33 PM EDT
Galera Therapeutics Market Cap
Galera Therapeutics has a market cap or net worth of $1.35 million as of October 16, 2025. Its market cap has decreased by -65.12% in one year.
Market Cap
1.35M
Enterprise Value
149.76M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since November 7, 2019, Galera Therapeutics's market cap has decreased from 292.35M to 1.35M, a decrease of -99.54%. That is a compound annual growth rate of -59.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 1.35M | -60.99% |
| Dec 31, 2024 | 3.46M | -56.28% |
| Dec 29, 2023 | 7.91M | -81.38% |
| Dec 30, 2022 | 42.47M | -65.01% |
| Dec 31, 2021 | 121.35M | -52.46% |
| Dec 31, 2020 | 255.25M | -21.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 698.88M |
| Elite Pharmaceuticals | 663.06M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 367.43M |
| CytoDyn | 350.21M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 275.85M |